Eli Lilly and Company
893 S Delaware St
Indianapolis
Indiana
46285
United States
About Eli Lilly and Company
Science has been our calling from the beginning. Colonel Eli Lilly founded the company in 1876 and charged employees to “take what you find here and make it better and better.” More than 147 years later, we remain committed to his vision through every aspect of our business and the people we serve, starting with discovering the best treatments for those who take our medicines and extending to health care professionals, employees and the communities in which we live. Moreover, you can also count on the team at Lilly to be incredibly civic-minded, supporting our communities through philanthropy, volunteerism, and a creative and innovative can-do spirit.
Karina found her fit at Lilly through our summer internship program. She is now hoping to inspire more Latinx students to make changes in the STEM field just as her mentor did for her. Visit careers.lilly.com/LRL to find open roles in Lilly’s research labs. #WeAreLilly
3430 articles about Eli Lilly and Company
-
Strides Arcolab Limited Inks Pact With Eli Lilly and Company for Cancer Drugs
12/5/2012
-
Anacor Pharmaceuticals, Inc. Announces Second Development Candidate in Animal Health Under Research Collaboration With Eli Lilly and Company
12/5/2012
-
Eli Lilly and Company Releases Update on Corporate Responsibility Efforts
12/3/2012
-
Eli Lilly and Company's ED Drug, Cialis, Shows Promise in Rare Muscle Disease
11/30/2012
-
Eli Lilly and Company Chief Says China Too Slow in Approving New Drugs
11/29/2012
-
Eli Lilly and Company to Present Record-Breaking $12.4 Million Gift to United Way
11/19/2012
-
Eli Lilly and Company Recognized as One of the Best Places to Work for LGBT Equality
11/19/2012
-
Johnson & Johnson, Eli Lilly and Company, Merck & Co., Inc. Team Up to Form Clinical Trial Site Database
11/15/2012
-
Incyte Corporation Wins $50 Million From Eli Lilly and Company as RA Drug Enters Phase 3
11/15/2012
-
Eli Lilly and Company and Incyte Corporation Announce Additional Phase IIb Baricitinib Data, Including MRI Results, in Patients With Rheumatoid Arthritis
11/14/2012
-
Eli Lilly and Company to Present Phase II Rheumatoid Arthritis and Biomarker Data at ACR for Two Investigational Medicines to Treat Autoimmune Diseases
11/9/2012
-
Eli Lilly and Company Release: Cardiovascular Outcome Study on Tradjenta® (Linagliptin) Tablets in Adult Patients With Type 2 Diabetes Completes Enrollment
11/8/2012
-
Eli Lilly and Company Statement on Hurricane Sandy Relief Efforts
11/2/2012
-
Big Pharmas Such as Roche. Eli Lilly and Company Crunch the Numbers to Boost Odds Against Cancer
11/2/2012
-
Eli Lilly and Company Trials Boost Amyloid Link to Alzheimer's in Two Phase 3 Studies
11/1/2012
-
Eli Lilly and Company to Expand Insulin-Manufacturing Facilities
10/31/2012
-
European Commission (EC) Approves Eli Lilly and Company's Cialis® (Tadalafil) Tablets for the Treatment of the Signs and Symptoms of Benign Prostatic Hyperplasia
10/30/2012
-
Eli Lilly and Company Names Melissa Barnes Chief Ethics and Compliance Officer and Senior Vice President; Announces Retirement of Anne Nobles
10/30/2012
-
Boehringer Ingelheim Corporation, Eli Lilly and Company Release: EU Approval Granted for Trajenta® (linagliptin) Tablets as Add-on Therapy to Insulin in Adults With Type 2 Diabetes
10/26/2012
-
Eli Lilly and Company Reports Third-Quarter 2012 Results
10/24/2012